• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Did use of long-acting reversible contraceptives increase after 2016 election?

Bioengineer by Bioengineer
February 4, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Bottom Line: Insertions of long-acting reversible contraceptive (LARC) methods increased in the 30 business days after the 2016 presidential election based on an analysis of data for a large group of commercially insured women. Industry and media reports after the 2016 election of Donald Trump described an increase in the utilization of LARC methods; one proposed reason was that women were concerned about access to contraceptives if the Patient Protection and Affordable Care Act (ACA) was repealed under the Trump administration. LARC methods (intrauterine devices and implants) can be effective for years at preventing pregnancy. This study of commercially insured women (more than 3.4 million in 2015 and more than 3.2 million in 2016) compared LARC utilization during the 30 days after the 2016 election with 30 days before the election and the same time period in 2015. In 2015, the average adjusted daily LARC insertion rate during the 30 business days before and including November 8 was 12.9 per 100,000 women compared with 13.7 per 100,000 women during the subsequent 30 days; the comparable averages before and after the 2016 election were 13.4 vs. 16.3 per 100,000 women. The authors acknowledge important limitations of their study including that they only studied women with commercial insurance.

Authors: Lydia E. Pace, M.D., M.P.H., of Brigham and Women’s Hospital, Boston, Massachusetts, and coauthors

(doi:10.1001/jamainternmed.2018.7111)

Editor’s Note: The article contains conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

###

Want to embed a link to this study in your story? This full-text link will be live at the embargo time: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2723071?guestAccessKey=0784ba9e-1dd9-46a3-92d7-9849b434a0e2

Media Contact
Johanna Younghans

[email protected]

Tags: Internal MedicineMedicine/Health
Share12Tweet7Share2ShareShareShare1

Related Posts

Predicting Lung Infections After Brain Hemorrhage

Predicting Lung Infections After Brain Hemorrhage

August 2, 2025
blank

Impact of Morphology and Location on Aneurysms

August 2, 2025

Unraveling EMT’s Role in Colorectal Cancer Spread

August 2, 2025

Gut γδ T17 Cells Drive Brain Inflammation via STING

August 2, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    40 shares
    Share 16 Tweet 10
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

BIOENGINEER.ORG

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Predicting Lung Infections After Brain Hemorrhage

Impact of Morphology and Location on Aneurysms

Unraveling EMT’s Role in Colorectal Cancer Spread

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.